Although the memory CD8+ T cell response after COVID-19 has declined over time and is generally lower than the memory CD4+ T cell response [29, 30], the proportion of AIM+ CD8+ T cells in our Conv18mVx1 group was particularly deficient in our study. The gene discussed is CD8A; the disease is COVID-19.